Manufacturer of Controlled Substances Notice of Registration, 22147 [2011-9620]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 76 / Wednesday, April 20, 2011 / Notices
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of Lin
Zhi International Inc., to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Lin Zhi International Inc.,
to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with State
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: April 13, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–9611 Filed 4–19–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances Notice of Registration
By Notice dated August 2, 2010, and
published in the Federal Register on
September 1, 2010, (75 FR 53721),
Chattem Chemicals Inc., 3801 St. Elmo
Avenue, Building 18, Chattanooga,
Tennessee 37409, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
schedules I and II:
srobinson on DSKHWCL6B1PROD with NOTICES
Drug
Schedule
4–Methoxyamphetamine (7411) ...
Dihydromorphine (9145) ...............
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Lisdexamfetamine (1205) .............
Methylphenidate (1724) ................
Pentobarbital (2270) .....................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Morphine (9300) ...........................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
VerDate Mar<15>2010
17:52 Apr 19, 2011
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Jkt 223001
Drug
Schedule
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Alfentanil (9737) ...........................
Reminfentanil (9739) ....................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Chattem Chemicals Inc. to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Chattem Chemicals Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: April 13, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–9620 Filed 4–19–11; 8:45 am]
BILLING CODE 4410–09–P
FOREIGN CLAIMS SETTLEMENT
COMMISSION
[F.C.S.C. Meeting Notice No. 2–11]
Sunshine Act Meeting
The Foreign Claims Settlement
Commission, pursuant to its regulations
(45 CFR part 504) and the Government
in the Sunshine Act (5 U.S.C. 552b),
hereby gives notice in regard to the
scheduling of meetings for the
transaction of Commission business and
other matters specified, as follows:
Date and Time: Tuesday, May 10,
2011, at 10 a.m.
Subject Matter: Issuance of Proposed
Decisions in claims against Albania and
Libya.
Status: Open.
All meetings are held at the Foreign
Claims Settlement Commission, 600 E
Street, NW., Washington, DC. Requests
for information, or advance notices of
intention to observe an open meeting,
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
22147
may be directed to: Executive Officer,
Foreign Claims Settlement Commission,
600 E Street, NW., Room 6002,
Washington, DC 20579. Telephone:
(202) 616–6975.
Judith H. Lock,
Executive Officer.
[FR Doc. 2011–9682 Filed 4–18–11; 4:15 pm]
BILLING CODE 6770–01–P
DEPARTMENT OF LABOR
Employment & Training Administration
[SGA–DFA–PY–10–03]
Solicitation for Grant Applications
(SGA); Trade Adjustment Assistance
Community College and Career
Training Grants Program; Amendment
Three
Employment and Training
Administration (ETA), Labor.
ACTION: Notice: Amendment to SGA/
DFA PY 10–03.
AGENCY:
The Employment and
Training Administration published a
notice in the Federal Register on
January 21, 2011, announcing the
availability of funds and Solicitation for
Grant Applications (SGA) for the Trade
Adjustment Assistance Community
College and Career Training grant
program (TAACCCT) to be awarded
through a competitive process. This
amendment to the SGA clarifies items
related to making portions of grant
applications publicly available. The
document is hereby amended.
In Section IIIG3, of the solicitation
(https://www.doleta.gov/grants/pdf/
SGA–DFA–PY–10–03.pdf), the following
text should be replaced:
Old Text—‘‘The Department is
committed to conducting a transparent
grant award process and publicizing
information about program outcomes.
Applicants are advised their application
and information related to its review
and evaluation (whether or not the
application is successful) may be made
publicly available, either fully or
partially. In addition, information about
grant progress and results may also be
made publicly available.’’
New Text—‘‘The Department is
committed to conducting a transparent
grant application and award process.
Among other things, posting grant
applications on public Web sites is a
means of promoting and sharing
innovative ideas. For this grant
competition, we will publish the
Technical Proposal required by Section
IVB, Part II for all those applications
that are awarded grants, on the
SUMMARY:
E:\FR\FM\20APN1.SGM
20APN1
]]>Agencies
[Federal Register Volume 76, Number 76 (Wednesday, April 20, 2011)]
[Notices]
[Page 22147]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-9620]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances Notice of Registration
By Notice dated August 2, 2010, and published in the Federal
Register on September 1, 2010, (75 FR 53721), Chattem Chemicals Inc.,
3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the basic classes of controlled
substances listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
4-Methoxyamphetamine (7411)................ I
Dihydromorphine (9145)..................... I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Lisdexamfetamine (1205).................... II
Methylphenidate (1724)..................... II
Pentobarbital (2270)....................... II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Meperidine (9230).......................... II
Methadone (9250)........................... II
Methadone intermediate (9254).............. II
Morphine (9300)............................ II
Oripavine (9330)........................... II
Thebaine (9333)............................ II
Oxymorphone (9652)......................... II
Noroxymorphone (9668)...................... II
Alfentanil (9737).......................... II
Reminfentanil (9739)....................... II
Sufentanil (9740).......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Chattem Chemicals Inc. to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Chattem Chemicals Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: April 13, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-9620 Filed 4-19-11; 8:45 am]
BILLING CODE 4410-09-P
